about
Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort studyThe PHF6 Mutation c.1A>G; pM1V Causes Börjeson-Forsman-Lehmann Syndrome in a Family with Four Affected Young Boys.Assessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study.The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional studyIncreased level of acute phase reactants in patients infected with modern Mycobacterium tuberculosis genotypes in Mwanza, Tanzania.Hypermethylated DNA, a circulating biomarker for colorectal cancer detectionEffectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study.Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, TanzaniaCD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection.The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania.Hepatitis C prevalence in Denmark -an estimate based on multiple national registers.Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel diseaseNationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations.Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania.Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, Tanzania.Genetic variants in the apoptosis gene BCL2L1 improve response to interferon-based treatment of hepatitis C virus genotype 3 infection.Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Hepatitis B among Inuit: A review with focus on Greenland InuitEffects of school meals with weekly fish servings on vitamin D status in Danish children: secondary outcomes from the OPUS (Optimal well-being, development and health for Danish children through a healthy New Nordic Diet) School Meal Study.Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 InfectionLiver biochemistry and associations with alcohol intake, hepatitis B virus infection and Inuit ethnicity: a population-based comparative epidemiological survey in Greenland and Denmark.Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney disease.Diabetes mellitus and impaired fasting glucose in ART-naïve patients with HIV-1, HIV-2 and HIV-1/2 dual infection in Guinea-Bissau: a cross-sectional study.The prevalence of latent Mycobacterium tuberculosis infection based on an interferon-γ release assay: a cross-sectional survey among urban adults in Mwanza, Tanzania.Socioeconomic status in HCV infected patients - risk and prognosis.Hepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle.Infrequency of low red blood cell (RBC) folate levels despite no folate fortification program: a study based on results from routine requests for RBC folate.Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor.Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.Historical epidemiology of hepatitis C virus (HCV) in selected countries.Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar.Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population.Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study.DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer: A Literature Review.A Danish nationwide questionnaire study of hepatitis B virus screening before immunosuppressive therapy.
P50
Q28479129-E5C1A0FE-0CBA-4C79-A326-41F818CDC538Q30387303-6C25DA58-5F47-4FC6-AF71-85EB0A4EF165Q31034250-D6762E33-BC24-461F-9BD1-E1E75A48E3B7Q33590163-A8C65DD0-3849-4E78-AF75-03DD06D7095AQ33734612-96A68002-23AB-4BD1-A55E-CC598AF7CDA9Q33756463-B897EDA4-A40D-4530-8198-AEA1DC1E02DFQ33897681-9E1D399C-05FB-47B2-A9E1-9176AB6B4C8AQ33938574-B753AFC3-5B6F-4967-8574-B6329E0B39A4Q34017697-42E72BFD-D61F-4B92-B1CD-A9909562F972Q34204890-DA375140-D8B1-4452-B84E-BFB35078D3E3Q34354494-5D33069D-FD0A-4294-B203-A1737A1CA3BBQ34367460-037A7098-E36B-47F8-B7AC-642D585404AAQ34487187-0C503A2B-49A7-4B4A-9943-162737285496Q34599453-FBC294E0-D790-4593-A4D6-72231E7ECB4DQ34707827-E0820DED-6CF0-4BEB-9644-584DD1A78F95Q34717544-C4A5DC69-4C2B-42C5-BCD1-F4DA8BA79811Q35063882-DCA760F6-0319-4237-AEF0-2A421AE068ECQ35139010-64244E26-E019-4064-9D75-B13057F990A8Q35557533-74B87568-5A49-4993-8E6D-30FD67E71B7DQ35622533-28F86CA5-8A54-4ECA-8C8B-BA5D4615162BQ35626787-2B7FA6C9-DC9C-431E-8AAD-07679FF0F0FEQ35818376-C9AFDCDB-EA26-4B72-BA4E-D1B5101E0C5CQ35861270-3912C167-3124-4EA2-B6A8-3964730677E4Q36014286-D46BE4A8-ABF8-48E5-88E3-8569886B62DEQ36635222-49D8980E-8E6D-4BDE-9F30-C9EB2DB0D341Q36729003-6B764DD1-CDD3-4BD9-A6FF-11D6B97549CBQ36794740-735AEBFB-00B0-4AC4-8A0A-596318D1FB30Q36863615-C8117508-5A6F-4702-A888-8B57CCCD9EEDQ36918975-39751A1D-BF6F-462D-8215-3DC124BF3BCCQ36933403-3D9DDAC2-9CCF-41CB-AA5D-C047A8614DB0Q37078384-A127ED0A-926D-4A70-B33D-9D5702493AA0Q37335699-D2865AD4-EF04-4CA8-A48E-2CDC9DD6AC8DQ37336496-DD058449-4571-42E6-A4A7-166BC5765E46Q38203033-C1A604A9-32BA-4604-983D-D989F5D770D6Q38218544-1CC4B9FF-7169-41E3-A530-752740C3E4CDQ38424625-A61B41D0-53A2-48B4-A51C-068634815100Q38426073-A8C60CC9-8575-4B22-98AB-6C61E55D301DQ38445289-E5930533-8027-4316-BD24-6094CAF74A70Q38584010-74477D0B-86BD-488F-91F9-604E84059343Q38928887-AC1EF3D5-D2F0-4219-9615-0821B78D40F7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Henrik Krarup
@ast
Henrik Krarup
@en
Henrik Krarup
@es
Henrik Krarup
@nl
Henrik Krarup
@sl
type
label
Henrik Krarup
@ast
Henrik Krarup
@en
Henrik Krarup
@es
Henrik Krarup
@nl
Henrik Krarup
@sl
prefLabel
Henrik Krarup
@ast
Henrik Krarup
@en
Henrik Krarup
@es
Henrik Krarup
@nl
Henrik Krarup
@sl
P106
P1153
7003874080
P21
P31
P496
0000-0001-5294-2428